Table 7.

 Overview of most cost effective vaccination strategy by country, vaccine availability, and immunity scenario

Variables	No immunity	Pre-existing immunity
Germany:
Early vaccination	Elderly people	High transmitters
Late vaccination	Elderly people	High transmitters
Netherlands:
Early vaccination	High transmitters	High transmitters
Late vaccination	Elderly people	High transmitters
United Kingdom:
Early vaccination	High transmitters	High transmitters
Late vaccination	Elderly people	High transmitters

Cost effectiveness is calculated using direct costs only. See table 6 for full results. Scenarios considered are no vaccination, vaccination of whole population, vaccination of elderly people, and vaccination of high transmitters (young people aged 5-19 years). Table 2 provides an overview of scenarios.